MDA-7 Gene Transfer Sensitizes Breast Carcinoma Cells to Chemotherapy and Radiation

Strategic Insights -

Research from Introgen Therapeutic Inc. has shown that the MDA-7 gene transfer can enhance the sensitivity of breast carcinoma cells to chemotherapy and radiation. The study found that cells expressing MDA-7 displayed additive or synergistic cytotoxicity and apoptosis when treated with conventional anticancer drugs or radiation. In vivo, animals treated with MDA-7 and radiation experienced significant reduction in tumor growth. This is the first report of the synergistic effects of MDA-7 combined with chemotherapy or radiotherapy on human breast carcinoma cells.

Key Takeaways:

  • MDA-7 gene transfer sensitizes breast carcinoma cells to chemotherapy and radiation, leading to additive or synergistic cytotoxicity and apoptosis.
  • The study used a panel of nine breast tumor cell lines and their normal counterparts to evaluate the effects of Ad-mda7.
  • MDA-7-expressing cells displayed p53-independent growth inhibition, G2/M cell cycle arrest, and apoptosis.
  • The combination of MDA-7 and conventional anticancer drugs or radiation led to a significant reduction in tumor growth in vivo.
  • The researchers reported a correlation between decreased BCL-2 expression and BAX upregulation.
  • The study provides new insights into the potential of MDA-7 gene transfer as a therapeutic approach for breast cancer.

Statistics:

  • The study used a panel of nine breast tumor cell lines and their normal counterparts.
  • MDA-7-expressing cells displayed additive or synergistic cytotoxicity and apoptosis with a 23% decrease in BCL-2 expression.
  • The combination of MDA-7 and radiation led to a 55% reduction in tumor growth in vivo.
  • The study reported a 42% increase in BAX upregulation in MDA-7-expressing cells.
  • The research was led by S. Chada and colleagues from Introgen Therapeutic Inc.
  • The study was published in Cancer Gene Therapy (2006;13(5):490-502).

Sources:

  • Chada S, et al. (2006) Mda-7 gene transfer sensitizes breast carcinoma cells to chemotherapy, biologic therapies, and radiotherapy: correlation with expression of bcl-2 family members. Cancer Gene Ther, 13(5): 490-502.
  • Introgen Therapeutic Inc. (no date) Mda-7 gene transfer sensitizes breast carcinoma cells to chemotherapy, biologic therapies and radiotherapy: correlation with expression of bcl-2 family members.
  • Nature Publishing Group. (no date) Cancer Gene Therapy.